Here are three insights:
1. The project is valued at $100 million.
2. Researchers will attempt to treat paralysis, depression, amputation, epilepsy and more.
3. The researchers will leverage a digital nervous system powered by optogenetics to try to treat paralysis and Parkinson’ disease. The end goal involves creating cells and tissues to grow organs that will repair biological parts.
More articles on devices:
TransEnterix submits additional information for surgical robotic system FDA clearance: 5 insights
Dr. Asif Ilyas completes 1st surgery using Globus Medical’s trauma fixation system: 5 takeaways
NuVasive, DePuy Synthes, Zimmer Biomet & more: 10 device company notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
